Fact CheckerSign in

NCT06153264Completed

Neural Mobilization on Multiple Sclerosis

Effect of Neurodynamic Mobilization Exercises on Pain, Muscle Strength and Manual Dexterity in Multiple Sclerosis Patients

Source: ClinicalTrials.gov · Last updated 21 Aug 2024

Brief summary (registry, in English)

Current treatments for pain in MS patients include the use of non-pharmacological interventions such as electrotherapy and exercise, as well as pharmacological treatments. Neurodynamic mobilization exercises are an intervention that aims to restore homeostasis in and around the nervous system by activating the nervous system itself or the structures surrounding the nervous system. Neurodynamic mobilization facilitates movement between neural structures and their environment through manual techniques and exercise. Human and animal studies reveal that neurodynamic mobilization reduces intraneural edema, improves intraneural fluid distribution, reduces thermal and mechanical hyperalgesia, and reverses increased immune responses following a nerve injury.

Status (registry)
Completed
Study type
Interventional
Enrollment
40 (actual)
First submitted
22 Nov 2023
Start date
15 Sept 2023
Primary completion date
15 Jun 2024
Lead sponsor
Kahramanmaras Sutcu Imam University
NCT number
NCT06153264

What you commit to

  • Study type: Interventional
  • Participants enrolled: 40
  • From 15 Sept 2023 to the primary completion date, 15 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Having a history of trauma within the last year
  • Having diabetes mellitus
  • Having another known neurological disease

Age

  • Being under 18 years of age and over 65 years of age

Other

  • Having alcohol and substance addiction
  • Being pregnant

Who the study is looking for

  • Being diagnosed with MS according to McDonald 2010 diagnostic criteria
  • Being between the ages of 18-65
  • Volunteering to participate in the study

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kahramanmaraş Sütçü imam University
Coordinator of this site? Confirm its status
KahramanmaraşTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.